Gennaro Giustino, MD (@g_giustinomd) 's Twitter Profile
Gennaro Giustino, MD

@g_giustinomd

🇮🇹 Structural Interventional Cardiologist @AtlanticHealth

ID: 234811939

linkhttps://scholar.google.com/citations?user=74J3LpkAAAAJ&hl=en calendar_today06-01-2011 16:43:59

916 Tweet

2,2K Followers

1,1K Following

vinayak bapat (@bapat_savrtavr) 's Twitter Profile Photo

What is the Obsession with ‘first in world’ for every small thing!! Are we confusing science & patient with focus on ‘publicity and popularism?’

Davide Capodanno (@dfcapodanno) 's Twitter Profile Photo

Everything we have learned so far about the revascularization of non-culprit lesions in patients with acute myocardial infarction and multivessel disease... in 1 minute.

Gennaro Giustino, MD (@g_giustinomd) 's Twitter Profile Photo

Heading towards the end of SHD fellowship, just another week at Henry Ford….. : - 4 transjugular TTVR evoque (all successful) - 1 transjugular PVL closure of an Evoque (no residual PVL) - 2 JenaValve for AI of which one in a quadricuspid aortic valve in a pt with an LVAD -

Gennaro Giustino, MD (@g_giustinomd) 's Twitter Profile Photo

And….. last case of SHD fellowship is a fully percutaneous left transaxillary TAVR S3 as a Live Case for SBHCI Dry access and closure technique. Biradial access, no groin. Ax artery Hemostasis achieved with 18Fr Manta. End of an era… I am forever grateful to Henry Ford Health

Mohamad Alkhouli (@adnanalkhouli) 's Twitter Profile Photo

The Reverse Paradigm: Business Driven Science. The rapid expansion of transcatheter Tx for tricuspid regurgitation, fueled initially by industry’s pursuit of profit following the success of TAVR, has exposed a critical gap in our understanding of the disease—a gap that could

The Reverse Paradigm: Business Driven Science.

The rapid expansion of transcatheter Tx for tricuspid regurgitation, fueled initially by industry’s pursuit of profit following the success of TAVR, has exposed a critical gap in our understanding of the disease—a gap that could
Dr. Yongcheol Kim (@yongcheolkim2) 's Twitter Profile Photo

Happy to share the review of article regarding Image-guided PCI, published in JACC Asia supported by the KSIC (Korea Society of Interventional Cardiology) and the IPOP (Imaging and Physiology with Cardiovascular Disease) jacc.org/doi/10.1016/j.…

Happy to share the review of article regarding Image-guided PCI, published in JACC Asia supported by the KSIC (Korea Society of Interventional Cardiology) and the IPOP (Imaging and Physiology with Cardiovascular Disease)

jacc.org/doi/10.1016/j.…
George Tolis (@georgetolisjr) 's Twitter Profile Photo

The reason why “novel” procedures do not get widely adapted is because they are either not reproducible or their proponents are hiding complications.

NEJM (@nejm) 's Twitter Profile Photo

RESHAPE-HF trial: Among patients with at least moderate functional mitral regurgitation, transcatheter valve repair led to a lower rate of heart failure events during 24 months and better health status at 12 months than medical therapy alone. nej.md/477rpaC #ESCardio

RESHAPE-HF trial: Among patients with at least moderate functional mitral regurgitation, transcatheter valve repair led to a lower rate of heart failure events during 24 months and better health status at 12 months than medical therapy alone. nej.md/477rpaC 

#ESCardio